Home » Stocks » PMV Pharmaceuticals

PMV Pharmaceuticals, Inc. (PMVP)

Stock Price: $35.66 USD 0.36 (1.02%)
Updated Oct 21, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 1.53B
Revenue (ttm) n/a
Net Income (ttm) -28.44M
Shares Out 43.00M
EPS (ttm) -0.66
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 21, 2020
Last Price $35.66
Previous Close $35.30
Change ($) 0.36
Change (%) 1.02%
Day's Open 35.35
Day's Range 34.44 - 36.45
Day's Volume 38,119
52-Week Range 31.50 - 42.93

More Stats

Market Cap 1.53B
Enterprise Value 1.45B
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 43.00M
Float 28.82M
EPS (basic) n/a
EPS (diluted) -0.66
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 186,922
Short Ratio 0.16
Short % of Float 0.65%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 10.47
Revenue n/a
Operating Income n/a
Net Income -28.44M
Free Cash Flow n/a
Net Cash 86.14M
Net Cash / Share 2.00
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA n/a
ROE n/a
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Operating Income-26.64-18.89
Net Income-25.35-17.54
Shares Outstanding3.043.01
Earnings Per Share-8.35-5.82
Operating Cash Flow-22.07-15.18
Capital Expenditures-0.11-0.45
Free Cash Flow-22.17-15.63
Cash & Equivalents10161.91
Net Cash / Debt10161.91
Book Value-70.47-46.14
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name PMV Pharmaceuticals, Inc.
Country United States
Employees 38
CEO David H. Mack

Stock Information

Ticker Symbol PMVP
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: PMVP
IPO Date September 25, 2020


PMV Pharmaceuticals, a precision oncology company, discovery and development of small molecule, tumor-agnostic therapies for p53 mutations in cancer. Its lead product candidate is PC14586, a small molecule that corrects and restores p53 function. The company also develops product candidates for p53 R273H hotspot mutation and other p53 hotspot mutations. PMV Pharmaceuticals, Inc. was formerly known as PJ Pharmaceuticals, Inc. and changed to in July 2013. The company was founded in 2013 and is headquartered in Cranbury, New Jersey.